Skip to main content

Animations

MJFF Publications

6821 - 6830 of 8808 Results
Title
Year
  • Year
  • 2013
  • 2016
  • 2020
  • 2016
  • 2023
  • 2013
  • 2015
  • 2021
  • 2025
  • 2012
  • Summary Details
    RESTRICTED
    Title: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20160557
    Citation Count: 170
  • Summary Details
    RESTRICTED
    Title: Carepartner Communication on Parkinson Disease Psychosis (4116)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116
    Citation Count: 0
  • Summary Details
    OPEN
    Title: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0130-3
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad026
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26170
    Citation Count: 282
  • Summary Details
    OPEN
    Title: Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.1c00290
    Citation Count: 44
  • Summary Details
    OPEN
    Title: A dual-functional substrate for quantitation of substrate levels and GCase activity in living cells
    Journal Name: RSC Chemical Biology
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d5cb00045a
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Alzheimer's disease: Pathogenesis and prevention
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.01.011
    Citation Count: 97
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.